Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination | Journal for ImmunoTherapy of Cancer
Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics - ScienceDirect
Serum IgA, IgM, and IgG responses in COVID-19 | Cellular & Molecular Immunology
Maternal IgG and IgA Antibodies Dampen Mucosal T Helper Cell Responses in Early Life: Cell
IDF Clinical Focus Primary Humoral Immunodeficiency Optimizing IgG Replacement Therapy (2003) | Immune Deficiency Foundation
IGG participates in new DFG Research Unit — IGG
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet
Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals. - eClinicalMedicine
Multiplexed and High-Throughput Label-Free Detection of RNA/Spike Protein/ IgG/IgM Biomarkers of SARS-CoV-2 Infection Utilizing Nanoplasmonic Biosensors | Analytical Chemistry
Description and Source of Serum Samples | Download Table
Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
Global profiling of SARS-CoV-2 specific IgG/ IgM responses of convalescents using a proteome microarray | medRxiv
An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies | Experimental & Molecular Medicine
Frontiers | Detection of Anti-SARS-CoV-2-S2 IgG Is More Sensitive Than Anti-RBD IgG in Identifying Asymptomatic COVID-19 Patients
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity | Science
Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay | Analytical Chemistry
Centenarians and extremely old people living with frailty can elicit durable SARS-CoV-2 spike specific IgG antibodies with virus neutralization functions following virus infection as determined by serological study - eClinicalMedicine
IgG N-glycome changes during the course of severe COVID-19: An observational study - eBioMedicine
Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors - ScienceDirect
Serum and Plasma Immunoglobulin G Fc N-Glycosylation Is Stable during Storage | Journal of Proteome Research
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma | bioRxiv
Synthetic nanobodies as tools to distinguish IgG Fc glycoforms | PNAS
Compromised SARS-CoV-2-specific placental antibody transfer - ScienceDirect
Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave | PLOS ONE
Synergistic convergence of microbiota-specific systemic IgG and secretory IgA - ScienceDirect
